BridgeBio Oncology Therapeutics Inc. (BBOT) vs Rocket Pharmaceuticals, Inc. (RCKT)
A side-by-side comparison of BridgeBio Oncology Therapeutics Inc. and Rocket Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RCKT
Rocket Pharmaceuticals, Inc.
$2.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BBOT vs RCKT
growth of $100 · dividends reinvested · last 3yBBOT -64.7% (-29.3%/yr)RCKT -91.1% (-55.3%/yr)BBOT compounded faster over this window
BBOT RCKT
BBOT vs RCKT: by the numbers
- •BBOT is the larger company ($280M vs $271M market cap).
Metrics side by side
Valuation
| Metric | BBOT | RCKT |
|---|---|---|
| P/B ratio | 0.87 | 0.73 |
Profitability
| Metric | BBOT | RCKT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -56.36% | -4.68% |
| ROIC | -61.10% | -48.92% |
Growth (annualized)
| Metric | BBOT | RCKT |
|---|---|---|
| Total return CAGR (5Y) | N/A | -38.33% |
Go deeper
Dig into the metrics
BridgeBio Oncology Therapeutics ROERocket Pharmaceuticals ROEBridgeBio Oncology Therapeutics operating marginRocket Pharmaceuticals operating marginBridgeBio Oncology Therapeutics revenue growthRocket Pharmaceuticals revenue growthBridgeBio Oncology Therapeutics free cash flowRocket Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.